Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

3.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.8K
Skin Cancer01:30

Skin Cancer

4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

831
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
831

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the Metabolic-Inflammatory Axis in Psoriasis and Psoriatic Arthritis: Evidence From Diet, Glucagon-like Peptide-1 Receptor Agonists, and Patient Perspectives.

The Journal of rheumatology·2026
Same author

Comparative outcomes of intra-aortic balloon pump versus impella in non-myocardial infarction cardiogenic shock: A National Inpatient Sample Database analysis.

JHLT open·2026
Same author

Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy.

The American journal of cardiology·2026
Same author

Alternative Methods in Microbial QC: Evaluating the Use of the ATCC MicroQuant™ as a Ready-To-Use Commercial Reference Microorganism Preparation on the Growth Direct® System: Poster Presented at PDA Microbiology Conference 2025.

PDA journal of pharmaceutical science and technology·2026
Same author

Developing a Comprehensive Organism Panel to Assess the Detection Capabilities of Growth Direct Rapid Sterility for Rapid Sterility Testing: Poster Presented at PDA Microbiology Conference 2025.

PDA journal of pharmaceutical science and technology·2026
Same author

Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials.

Nature reviews. Rheumatology·2026

Related Experiment Video

Updated: Jul 1, 2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:38

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

72

Dermatomyositis: Practical Guidance and Unmet Needs.

Lydia Cassard1, Noelle Seraly2, Maureen Riegert3

  • 1Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, OH, USA.

Immunotargets and Therapy
|March 11, 2024
PubMed
Summary
This summary is machine-generated.

Dermatomyositis diagnosis relies on clinical, serological, and histological findings, with autoantibodies aiding identification. New research explores targeted therapies and high-risk malignancy screening for this inflammatory myopathy.

Keywords:
MDA-5autoantibodyidiopathic inflammatory myopathymalignancymyositistreatment

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.9K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.2K

Related Experiment Videos

Last Updated: Jul 1, 2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:38

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

72
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.9K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.2K

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Background:

  • Dermatomyositis is a complex idiopathic inflammatory myopathy.
  • It presents with diverse skin issues and potential organ involvement.
  • Accurate diagnosis is crucial and challenging.

Purpose of the Study:

  • To highlight key diagnostic features of dermatomyositis.
  • To discuss the role of myositis-specific autoantibodies.
  • To review current and emerging treatment strategies and malignancy screening.

Main Methods:

  • Correlation of clinical, serological, and histological findings.
  • Identification of pathognomonic and common cutaneous manifestations.
  • Review of autoantibody associations and systemic manifestations.

Main Results:

  • Cutaneous manifestations are key diagnostic indicators.
  • Myositis-specific autoantibodies refine diagnosis and guide workups.
  • Malignancy screening in dermatomyositis requires careful consideration of risk-benefit.

Conclusions:

  • Accurate dermatomyositis diagnosis integrates multiple data types.
  • Novel therapies are needed, especially for interstitial lung disease.
  • Emerging research offers hope for improved patient outcomes.